Genmab A/S (GMAB) — Financial statements
Income statement, balance sheet, and cash flow for Genmab A/S — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 3,723↓82.7% | 21,526↑30.7% | 16,474↑13.6% | 14,505↑72.3% | 8,417 | |
| Cost of Revenue | 309↓68.6% | 985↑335.8% | 226 | 0.00 | 0.00 | |
| Gross Profit | 3,414↓83.4% | 20,541↑26.4% | 16,248↑12.0% | 14,505↑72.3% | 8,417 | |
| Operating Expenses | ||||||
| R&D Expenses | 1,560↓84.0% | 9,748↑27.8% | 7,630↑37.2% | 5,562↑33.0% | 4,181 | |
| General & Administrative Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 602↓84.1% | 3,790↑15.0% | 3,297↑23.2% | 2,676↑108.6% | 1,283 | |
| Other Expenses | 0.00↓100.0% | 300 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 2,163↓84.4% | 13,838↑26.6% | 10,927↑32.6% | 8,238↑50.8% | 5,464 | |
| Total Costs & Expenses | 2,472↓83.3% | 14,823↑32.9% | 11,153↑35.4% | 8,238↑50.8% | 5,464 | |
| Operating Results | ||||||
| Operating Income | 1,251↓81.3% | 6,703↑26.0% | 5,321↓15.1% | 6,267↑112.2% | 2,953 | |
| Depreciation & Amortization | 71↓82.8% | 413↑72.1% | 240↓33.7% | 362↑44.8% | 250 | |
| EBITDA | 1,322↓86.4% | 9,697↑63.1% | 5,947↓19.0% | 7,346↑75.7% | 4,181 | |
| EBIT | 1,251↓86.5% | 9,284↑62.7% | 5,707↓18.1% | 6,966↑77.2% | 3,931 | |
| Interest & Other Income | ||||||
| Net Interest Income | 77↓91.2% | 875↓4.1% | 912↑201.0% | 303↑64.7% | 184 | |
| Interest Income | 138↓86.1% | 995↑6.0% | 939↑189.8% | 324↑64.5% | 197 | |
| Interest Expense | 61↓49.1% | 120↑344.4% | 27↑28.6% | 21↑61.5% | 13 | |
| Non-Operating Income | 0.00↑100.0% | -2,581↓568.7% | -386↑44.8% | -699↑28.5% | -978 | |
| Other Income / Expenses | -46↓101.9% | 2,461↑678.8% | 316↓53.4% | 678↓29.7% | 965 | |
| Income Before Tax | 1,205↓86.9% | 9,164↑62.6% | 5,637↓18.8% | 6,945↑77.3% | 3,918 | |
| Income Tax Expense | 241↓81.7% | 1,320↑2.7% | 1,285↓13.9% | 1,493↑55.4% | 961 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 964↓87.7% | 7,844↑80.2% | 4,352↓20.2% | 5,452↑84.4% | 2,957 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 964↓87.7% | 7,844↑80.2% | 4,352↓20.2% | 5,452↑84.4% | 2,957 | |
| Bottom-Line Net Income | 964↓87.7% | 7,844↑80.2% | 4,352↓20.2% | 5,452↑84.4% | 2,957 | |
| EPS (Basic) | 1.55↓87.2% | 12.14↑83.9% | 6.60↓20.9% | 8.34↑84.5% | 4.52 | |
| EPS (Diluted) | 1.54↓87.3% | 12.14↑83.9% | 6.60↓20.1% | 8.26↑84.4% | 4.48 | |
| Weighted Average Shares | 622↓3.8% | 646↓1.9% | 659↑0.8% | 654↓0.0% | 654 | |
| Weighted Average Diluted Shares | 627↓3.0% | 646↓1.9% | 659↓0.1% | 660↓0.1% | 660 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.